Per 0.5 mL Recombinant pertussis toxin 5 mcg, filamentous hemagglutinin 5 mcg
Indications/Uses
Active booster immunization against pertussis in individuals ≥3 yr. Passive protection against pertussis in early infancy following maternal immunization during pregnancy.
View Pertagen overdosage for action to be taken in the event of an overdose.
Contraindications
History or signs of severe allergic reaction or any encephalopathy w/ unknown origin; neurological disorders, uncontrolled epilepsy or progressive encephalopathy.
Postpone vaccination in case of acute severe febrile illness, immunosuppressive treatment or immunodeficiency. Patients who had high body temp (≥40°C) w/o any identifiable cause w/in 48 hr after previous immunization w/ any pertussis vaccines. Patients receiving anticoagulant therapy or those w/ thrombocytopenia or any coagulation disorder. Review medical history & have clinical exam prior to vaccination.
Sign Out
